Evolocumab Added to Statins to Reduce Progression of Coronary Atherosclerosis-Reply

Affiliations

¹ South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia.
² Amgen, Thousand Oaks, California.
³ Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

Comment

Stephen J Nicholls et al. JAMA. 2017.

. 2017 Apr 25;317(16):1691.

doi: 10.1001/jama.2017.3449.

¹ South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia.
² Amgen, Thousand Oaks, California.
³ Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

No abstract available

Comment on

Evolocumab Added to Statins to Reduce Progression of Coronary Atherosclerosis.
Murray SW. Murray SW. JAMA. 2017 Apr 25;317(16):1690. doi: 10.1001/jama.2017.3440. JAMA. 2017. PMID: 28444270 No abstract available.
Evolocumab Added to Statins to Reduce Progression of Coronary Atherosclerosis.
Alkhalil M, Choudhury RP. Alkhalil M, et al. JAMA. 2017 Apr 25;317(16):1690-1691. doi: 10.1001/jama.2017.3443. JAMA. 2017. PMID: 28444271 No abstract available.